Back
Stereotaxis 10K Form
Sell
29
STXS
Stereotaxis
Last Price:
2.39
Seasonality Move:
-2.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive STXS News And Ratings
See the #1 stock for the next 7 days that we like better than STXS
STXS Financial Statistics
Sales & Book Value
| Annual Sales: | $26.77M |
|---|---|
| Cash Flow: | $-2.44M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.20 |
| Price / Book: | 12.86 |
Profitability
| EPS (TTM): | -0.27000 |
|---|---|
| Net Income (TTM): | $-20.71M |
| Gross Margin: | $14.86M |
| Return on Equity: | -77.05% |
| Return on Assets: | -43.36% |
Stereotaxis Earnings Forecast
Key Stereotaxis Financial Ratios
- The Gross Profit Margin over the past 24 years for STXS is 55.51%.
- The Selling, General & Administrative Expenses for STXS have been equal to 98.71% of Gross Profit Margin.
- The Research & Development expenses have been 38.37% of Revenue.
- The Interest Expense is 16.67% of Operating Income.
- The Net Earning history of STXS is -77.37% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 13 years.
Stereotaxis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | STXS |
| CUSIP: | 85916J |
| Website: | stereotaxis.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.51 |
| Quick Ratio: | 1.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
STXS Technical Analysis vs Fundamental Analysis
Sell
29
Stereotaxis (STXS)
is a Sell
Is Stereotaxis a Buy or a Sell?
-
Stereotaxis stock is rated a Sell
The current Stereotaxis [STXS] share price is $2.56. The Score for STXS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.